Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05935007 · ClinicalTrials.gov registry record
Aveir DR Real-World Evidence Post-Approval Study
A clinical trial of Bradycardia and Arrythmia, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 1,805
- Enrollment target
- 1
- Study location
NCT05935007 is a study of Bradycardia and Arrythmia that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 1,805 participants, below the 4,350-participant average among 29 other Bradycardia trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05935007, a study of Bradycardia and Arrythmia, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 1,805 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.
Conditions Studied
Interventions
- DEVICE Aveir DR Leadless Pacemaker System
Study Locations (1)
California
- Abbott - Sylmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,805 participants |
| Start Date | 2023-10-31 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05935007
The ClinicalTrials.gov registry entry for NCT05935007 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,805 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,350-participant average among 29 other Bradycardia trials with a reported enrollment target (59% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Aveir DR Leadless Pacemaker System is the first listed.
NCT05935007 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05935007 about?
NCT05935007 is a clinical study titled "Aveir DR Real-World Evidence Post-Approval Study". The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.
What is the current status of trial NCT05935007?
This trial is currently recruiting. The enrollment target is 1,805 participants. The study started on 2023-10-31. Estimated completion is 2030-01.
What conditions does trial NCT05935007 study?
This clinical trial studies the following conditions: Bradycardia, Arrythmia, Cardiac Pacemaker.
What interventions are being tested in trial NCT05935007?
The interventions under investigation include: Aveir DR Leadless Pacemaker System (DEVICE).
Who is sponsoring clinical trial NCT05935007?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05935007 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Aveir VR Real-World Evidence Post-Approval Study
RECRUITING
-
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RECRUITING
-
The Alaska Oculocardiac Reflex Study
RECRUITING
-
His Bundle Pacing in Bradycardia and Heart Failure
RECRUITING
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.